MIT researchers have developed an ingestible device that is powered by stomach acid and can deliver drugs for up to one week, reports Brooks Hays of UPI. "Our work helps pave the way toward a new era of pill-sized electronics, which can operate over the course of weeks or even months in the gastrointestinal tract,” says Giovanni Traverso, a research affiliate at the Koch Institute.
MIT researchers have developed a pill that uses stomach acid to run sensors in the body and can deliver drugs over a long period of time, writes Hallie Smith of Boston Magazine. By attaching zinc and copper electrodes to the exterior of the pill it “reacts with stomach acid to create electricity,” explains Smith.
MIT researchers have developed a new drug capsule that can deliver doses of medication over the course of several weeks, reports Robby Berman for Slate. Berman explains that the star-shaped device is like “a little pharmacy stationed in the stomach, ready to dispense doses at the desired times.”
Prof. Robert Langer speaks with Kathryn Nave of Wired about the future of drug delivery. Langer explains that a problem facing medical professionals is that many drugs are not taken regularly or as prescribed, and describes how he is developing a “long-acting pill that you could swallow to release the right drug dosage for weeks.”
A new drug delivery system developed by MIT researchers may help eradicate malaria and could boost medication adherence, writes Rachel Zimmerman for WBUR’s Bostonomix. "People don't take their medicines and this might be a way, someday, for Alzheimer's patients to have much better treatments and people with mental health diseases to have much better treatments," says Prof. Langer.
MIT researchers have devised a capsule that can deliver medications over extended periods of time, and could be useful in halting the spread of malaria. The Economist notes that the device could be a “useful addition to the armory being deployed against malaria. And that, alone, could save many lives a year.”
Bob Tedeschi writes for STAT that MIT researchers have developed a device that can remain in the stomach for up to two weeks, gradually releasing medication. “The capsule represents the latest effort to solve a major flaw in drug delivery,” Tedeschi explains. “Because the human stomach clears its contents multiple times daily, pill takers must dose themselves frequently.”
MIT researchers have developed a new drug delivery capsule that can deliver medication over extended periods of time, reports Claire Maldarelli for Popular Science. Once in the stomach, the capsule opens into a star shape, which “prevents the pill from leaving the stomach and entering the small intestine.”
Researchers at MIT have developed a slow-release drug capsule that can last two weeks in a person’s stomach, writes Jamie Ducharme for Boston Magazine. “The capsule was tested for use in malaria prevention, but the researchers behind it say it could be used for virtually any condition that requires regular oral medication,” Ducharme explains.
Reuters reporter Kate Kelland writes that MIT researchers have created a new drug-delivery capsule that can stay in the stomach for up to two weeks after being swallowed. The star-shaped device could be “a powerful weapon in fighting malaria, HIV and other diseases where successful treatment depends on repeated doses of medicine.”
MIT researchers have developed a star-shaped, drug-delivery device that can stay in the stomach for up to two weeks, gradually releasing medication, reports Melissa Healy for The Los Angeles Times. The researchers believe the device could be useful in “delivering a wide range of medications for diseases in which patient non-adherence is a problem.”
MIT researchers have developed a stretchy, biocompatible material that could be implanted in a patient’s body and used to stimulate cells or detect disease, according to FOX News. The hydrogel “could bend and twist in a patient’s body without breaking down.”
MIT researchers have developed a new technique to stop the spread of cancer cells through the body by delivering microRNAs to the site of the primary tumor, reports Hallie Smith for Boston Magazine. The technique “may correct gene disruptions that put a patient at risk of metastatic cancer,” Smith explains.
In a Huffington Post video, Prof. Daniela Rus explains that the ingestible origami robot her team developed could enable incisionless surgery. “What we have developed so far is a proof of concept that shows that you could have tetherless machines that can do active and important functions inside the body,” she explains.
Popular Science reporter Sarah Chodosh writes that MIT researchers have developed a strategy to deliver beneficial bacteria to the GI tract. The researchers used layers of different sugars "to coat individual cells of Bacillus coagulans, which is used to treat irritable bowel syndrome."